Rui Yu

8PUBLICATIONS
19CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 24, 2026
RON receptor tyrosine kinase regulates abiraterone resistance in prostate cancer via the methylation-dependent and independent dual functions of DNMT1.

|Jun 30, 2026
RNF113A Protects Against Sepsis-Induced Myocardial Injury via Activation of the Keap1/Nrf2 Axis to Reduce Ferroptosis.

|Jul 21, 2022
SBP-0636457, a Novel Smac Mimetic, Cooperates with Doxorubicin to Induce Necroptosis in Breast Cancer Cells during Apoptosis Blockage.

Rui Yu, Lei Wang, Xiaochun Ji

|Feb 03, 2021
Emodin Induced Necroptosis and Inhibited Glycolysis in the Renal Cancer Cells by Enhancing ROS.

Ke-Jie Wang, Xiang-Yu Meng, Jun-Feng Chen

|Nov 07, 2020
Low expression of hsa_circ_0001811 in gastric cancer and its role in clinical diagnosis.

Haiyan Zhang, Zhe Li, Yao Ruan

|Jul 31, 2020
A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.

Rui Yu, Jie Yao, Yu Ren

Pageof 2

Frequent Collaborators

2 joint publications

Ke-Jie Wang

2 joint publications

Qi Ma

1 joint publications

Zhen Cai

1 joint publications

Yu Ren